TheraRadar
← Back
Data updated: Mar 29, 2026

MOVA

OncologyCardiovascularRespiratory
Generics

MOVA is a generic drug manufacturer focused on Oncology, Cardiovascular, Respiratory.

1994
Since
1
Drugs
-
Trials
5
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

ALBUTEROL SULFATE 2025-12-01
ALBUTEROL SULFATE 2025-11-21
Labeling
ALBUTEROL SULFATE 2025-03-12
ALBUTEROL SULFATE 2024-05-21
ALBUTEROL SULFATE 2024-05-03
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 38%
0 drugs Phase 2: 1 Phase 1: 3
Cardiovascular 31%
0 drugs Phase 2: 2
Respiratory 31%
0 drugs Phase 2: 2

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Oncology, Cardiovascular, Respiratory
AstraZeneca big-pharma
Oncology, Respiratory, Cardiovascular
Boehringer Ingelheim big-pharma
Oncology, Respiratory, Cardiovascular
GE HEALTHCARE specialty
Cardiovascular, Oncology, Respiratory
BRACCO specialty
Cardiovascular, Oncology, Respiratory